Skip to content

A clinical study to evaluate the efficacy and safety of fairness cream in healthy, adult human volunteers.

A Controlled, Randomized, Double blind, parallel treatment, clinical trial evaluate the efficacy and safety of fairness cream in healthy, adult female volunteers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2009/091/000918
Enrollment
105
Registered
2009-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NA: Control Intervention1: NA:

Sponsors

ITC Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female Subjects in 18 to 30 yrs age group. 2. Female subjects with all skin types ? Dry, Normal & Oily. 3. Healthy, human subjects having Chromameter ?L? value < 50 on the cheeks. 4. You must have not participated similar kind of investigation in the past four weeks and have not applied any skin glowing cream in the past four weeks. 5. If you have medium to dark pigmented skin. 6. Willing to give informed written consent and comply with the study requirements. 7. If you are evaluated by demography, personal history and medical history.

Exclusion criteria

Exclusion criteria: 1. History of hypersensitivity to any cream and related products. 2. Hyperpigmentation and Skin disorders like atopic dermatitis, Dry skin, psoriasis, scabies and any other co-morbid conditions with the conscent of the investigators. 3. If you are currently pregnant or breastfeeding If you have fulfilled all entry criteria you will be randomized to either skin cream (T1) or skin cream (T2) or skin cream (T3) group in a 1:1:1 ratio.

Design outcomes

Primary

MeasureTime frame
Self assessment of brightness, glowing skin, radiant skin and overall fairness in a 10-point scale.Timepoint: Every 2 hours upto 12 hours.

Secondary

MeasureTime frame
Dermat overall fairness assessment in a 10 point scale and chromameter L* a* b* values in a 100 point scale.Timepoint: Every 2 hours upto 12 hours.

Countries

India

Contacts

Public ContactMurugan. P
vasanthi@huclin.in044-22540200

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026